Medicines optimisation · September 2026
Medicines optimisation in Somerset ICB
NHS Somerset Integrated Care Board has 13 PCNs and 599,417 registered patients. These are its headline figures for September 2026 from NHSBSA’s prescribing data.
- Price-per-unit savings
- £123,753in one month
- Per 1,000 registered patients
- £206England: £257
- DOAC prescriptions that were best value
- 84%England: 83%
- Ghost generics
- £10,588at 10 practices, part of the price-per-unit savings
Price per unit
In September 2026, practices in Somerset could have saved £123,753 by paying what the cheapest tenth of practices in England paid for the same medicines. That is £206 for every 1,000 registered patients, the 29th highest of England’s 36 ICBs.
Best value DOACs
16,110 of 19,153 DOAC prescriptions (84%) were generic apixaban or rivaroxaban tablets, NHS England’s joint best value DOACs. They cost £2.43 a prescription. The other 3,043 cost £48.24 a prescription. Changing anyone’s anticoagulant is a clinical decision made with the patient after a review, so we show the difference in cost, not a saving.
Ghost generics
10 practices prescribed generic medicines as one maker’s product instead of by their generic name, with £10,588 of price-per-unit savings on them in the month. This is part of the price-per-unit savings above, not extra to them.
Project work
Get a delivery plan for Somerset
You know the data. The hard part is the time to do the work, practice by practice. Tell us the project and we’ll send a plan:
- which practices to start with, and why
- the work your prescribing scheme already pays practices for
- how many pharmacist sessions it needs
Then we place clinical pharmacists to do it, for as long as the project needs.
How we work these out
Every figure is one month, September 2026, from NHSBSA’s English Prescribing Dataset for GP practices, as the data gives it: no saving is estimated or scaled up to a year.
- Price-per-unit savings are what each practice would have saved if it had paid what the cheapest tenth of practices in England paid per unit for the same medicine, counted where the practice would save at least £10 on that medicine in the month. This is OpenPrescribing’s price-per-unit method. Some savings can’t be made, for example where a medicine is short or on price concession.
- Ghost generics are generic medicines prescribed as one maker’s product instead of by their generic name, where England mostly prescribes the generic. They are part of the price-per-unit savings, not extra to them.
- Best value DOACs are generic apixaban and generic rivaroxaban tablets, NHS England’s joint best value direct-acting oral anticoagulants. We show the cost per prescription of each group, not a saving: changing anyone’s anticoagulant is a clinical decision made with the patient after a review.
Sources
- English Prescribing Dataset (NHSBSA), September 2026: items, quantities and cost by practice and medicine
- Commissioning recommendations for national procurement for DOACs (NHS England): which DOACs are best value
- OpenPrescribing (Bennett Institute, University of Oxford): the price-per-unit method
Contains public sector information licensed under the Open Government Licence v3.0.